Industry Discussions

How Long Do Clinical Trials Take?


ORR in Clinical Trials | ctms | clinical trial management system

Objective Response Rate (ORR) in clinical trials is the proportion of patients demonstrating either a partial response (PR) or a complete response (CR) to a specific treatment. It excludes stable disease and provides a direct quantitative measure of the treatment’s ability to induce a meaningful reduction or elimination of tumours.

ORR serves as a key endpoint, assisting in the assessment of treatment efficacy, guiding clinical decisions, and informing regulatory considerations.

Let’s discuss in detail what is ORR in clinical trials and how it is calculated.

Understanding ORR in Clinical Trials

Objective Response Rate is a critical endpoint in clinical trials that helps assess the proportion of patients whose tumours show a predefined degree of shrinkage or response following treatment.

Here are precise details of what is ORR in clinical trials and how it helps:

Quantify Treatment Efficacy

ORR is leveraged as a quantitative measure of a treatment’s efficacy in inducing a favourable change in tumour size. During the clinical trial, ORR provides a clearer picture of the drug’s tumoricidal activity by addressing partial and complete responses with accuracy.

Benchmark for Treatment Success

In clinical research, especially in oncology trials, the primary goal is to shrink or eliminate tumours. ORR is often used as a benchmark for the success of the clinical trial, indicating the exact proportion of patients experiencing a meaningful response to the treatment.

Informed Clinical Decision-Making

Clinical trial researchers rely on ORR data to make informed decisions about the viability and potential adoption of a particular treatment. A high ORR may signal a promising therapeutic approach, whereas a lower rate may prompt further investigation or refinement of the treatment strategy.


CTMS plays a vital role in managing and ensuring the accuracy of data critical to the ORR assessment in clinical trials.

Calculating ORR in Clinical Trials

The clinical researchers are required to gather data on the percentage of patients who achieve a complete response (CR) and those who achieve a partial response (PR) for ORR calculation. Simply add these percentages together and then divide the sum by the total number of evaluable patients to get the objective response rate (ORR).

The formula for ORR calculation in clinical trials is:
ORR = (CR+PRTotal Evaluable Patients) / RR = ( Total Evaluable Patients CR+PR ) ×100

Final Words

ORR in clinical trials measures how well a treatment works by checking the percentage of patients with a positive response. It helps compare treatments, informs regulatory decisions, and tells us if a treatment is successful.

High ORR can contribute to the evidence required for regulatory approval of a new drug, especially when it demonstrates a substantial impact on tumour size or elimination. Therefore, it is a good practice to calculate the objective response rate in a clinical trial.

Related Articles

ctms | clinical trial management system | clinical research


Industry News

The Ultimate Guide to Understanding What is a CTMS

A Clinical Trial Management System (CTMS) is a specialised, all-encompassing project management software tailored to guide a research team from the study’s inception—through the enrolment and oversight phases to the study’s conclusion… 


How Long Do Clinical Trials Take | CTMS | Realtime CTMS | Clinical trial management system


Industry News

How Long Do Clinical Trials Take?

According to Cancer Research UK, the timeline for drug testing and approval varies widely. There’s no fixed duration, but completing all phases of clinical trials even with the help of a CTMS, may take 10 to 15 years or more. This timeline includes license issuance as well…


Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top

Let's meet

Learn how to optimise your site! Join us for valuable lessons, in-depth discussion, and an exclusive demo of our AQ platform